Skip to content
patentreply.ai
Office Action responsePricingSecurityDocs

US 8,114,833 · Application 11/435,977

US Patent 8,114,833 — assignment history and current owner

Propylene Glycol-containing Peptide Formulations Which Are Optimal For Production And For Use In Injection Devices

Who owns US Patent 8,114,833?

US8114833 ("Propylene Glycol-containing Peptide Formulations Which Are Optimal For Production And For Use In Injection Devices") — current assignee: NOVO NORDISK A/S. Status: Expired. 1 recorded USPTO assignment.

Based on recorded USPTO assignment data, the apparent operating assignee of US Patent 8,114,833 is NOVO NORDISK A/S. Based on the most recent ownership transfer record (recorded 2006-09-08).

Patent title
Propylene Glycol-containing Peptide Formulations Which Are Optimal For Production And For Use In Injection Devices
Application number
11/435,977
Apparent operating assignee
NOVO NORDISK A/S
Patent status
Expired
Recorded assignments
1

Recorded assignment history

ExecutedRecordedConveyanceAssignor(s)Assignee(s)Reel/frame
Jul 18, 2006Sep 8, 2006Ownership TransferPEDERSEN, TINA BJELDSKOV; ENGELUND, DORTHE KOT; BONDE, CLAUDENOVO NORDISK A/S18240/830

Scrolls sideways on narrow screens

Chain of title

In 2006, PEDERSEN, TINA BJELDSKOV; ENGELUND, DORTHE KOT (+1 more) assigned the patent to NOVO NORDISK A/S.

When does this patent expire?Look up another patent

Apparent recorded rights summary — disclaimer

This tool presents recorded assignment data from the USPTO assignment database. It does not constitute a legal opinion on ownership or title. Assignments may exist that have not been recorded. Corrective records, off-record transfers, court orders, and other events may affect actual ownership. Consult a qualified patent attorney for definitive title analysis.

The prosecution record for your AI

Application 11/435,977 · US 8,114,833

Ownership settled? Give your AI the file.

The recorded chain of title is one part of the record. PatentReply compiles the rest of US 8,114,833, from the claims as filed to the last action, for Claude, ChatGPT, Cursor, or another supported AI workspace.

One new public application a month is free. The first compile takes a few minutes.

Connect PatentReplySee the evidence

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Data sourced from public USPTO assignment records. This tool provides informational summaries and should not be relied upon as legal advice or a definitive title opinion. Always verify patent ownership independently, especially where unrecorded transfers, court orders, or other off-record events may apply.

patentreply.ai
How it worksOffice Action responsePricingDocsConnectToolsSecurityPrivacyTermsContact

© 2026 patentreply.ai

PatentReply does not train on your matters. PatentReply is not a law firm and does not practice law; it requires attorney involvement where legal judgment belongs, and you remain the practitioner of record.